Jalapeno Golf Classic Hole in One prizes

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Golfers are coming in from Austin and Corpus Christi to play in the annual RGV Hispanic Chamber’s “Jalapeno Golf Classic” scheduled for Thursday Oct. 16th at Palm View Golf Course in McAllen.  Prizes include Longest Drive and Closest to the Pin as well as Hole – In- One sponsors South Texas Buick GMC, a Rolex watch from Deutsch & Deutsch, Clark Knapp Honda and Frank Smith Toyota.  Golfers will get to have lunch as they register at 12:00 noon.  The 4 man tournament will tee off at 1:00pm.  A dinner will also be provided at the Awards Presentation.

Golfers will get snacks and beverages out on the course, as well as massages during and after they finish their play.

1st Place team will win $1000, 2nd place $750 and 3rd place $500.  Other great door prizes will also be provided as well as 2 tickets on Southwest Airlines.  Teams are $500, Hole sponsors are $100, and sponsorships are:  shirt $5000, Cap $3,000,  golf balls $2,000, Goody Bags $2,000 and Towel $1,500.  There are only a few team openings left.

- Advertisement -

For more information call the RGVHCC at 928-0060.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Cybersecurity Alert as Hackers Exploit Computer and Smartphone Vulnerabilities

Federal cybersecurity authorities are urging computer and smartphone users to keep their devices updated following reports of actively exploited security vulnerabilities affecting Apple products and Google’s Chrome browse

American Cancer Society Updates Prostate Cancer Screening Guideline

The American Cancer Society (ACS) released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease.

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 
- Advertisement -